Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5576369 | The American Journal of Medicine | 2017 | 4 Pages |
Abstract
The efficacy of tolvaptan in patients with cirrhosis and severe hypervolemic hyponatremia seems to be limited.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Elisa MD, Elsa MD, PhD, Salvatore MD, PhD, Elisabetta MD, Isabel MD, Mónica MD, PhD, Andrés MD, PhD, Paolo MD, PhD, Pere MD, PhD,